MRKR: Marker Therapeutics, Inc. Common Stock Company Profile & Statistics

Marker Therapeutics, Inc. Common Stock Profile

About

Marker Therapeutics, Inc. is a clinical-stage immuno-oncology company specializing in the development of innovative peptide and nucleic acid-based immunotherapeutic vaccines for the treatment and eradication of cancer, including metastatic cancer. The company's product pipeline consists of MultiTAA T Cell Therapy, TPIV200 and TPIV100/110 which are in clinical stage. Marker Therapeutics Inc., formerly known as TapImmune Inc., is based in FL, United States.

Info & Links

CEO

Juan Vera

Headquarters

2450 Holcombe Blvd, Suite BCM-A
Houston, TX 77021, UNITED STATES

Auditor

Marcum LLP

Share holders

Employees

Marker Therapeutics, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization²

12.41M

Enterprise Value

593.41K

Enterprise Value/EBITDA(ttm)

-0.04

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

2.29

Price to Book(mrq)

1.03

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

100.00%

Operating Margin(ttm)

-271.10%

Profit Margin(ttm)

-507.54%

Return on Equity(ttm)

-114.59%

Return on Invested Capital(ttm)

-120.62%

Return on Assets(ttm)

-90.31%

Income Statement

Revenue(ttm)

5.39M

Revenue Per Share(ttm)

0.42

Gross Profit(ttm)

5.39M

EBITDA(ttm)³

-15.13M

Net Income Available to Common(ttm)

-14.61M

Diluted EPS(ttm)

-1.37

Share Statistics

Beta (5Y Monthly)

1.47

52-Week Change

-64.01%

S&P 500 52-Week Change

17.90%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

12.94M

Dividend Yield

0.00%

Float⁴

11.93M

% Held by Insiders

7.80%

% Held by Institutions

22.39%

Balance Sheet

Total Cash(mrq)

11.81M

Total Cash Per Share(mrq)

0.91

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

3.45%

Quick Ratio(mrq)

3.45%

Book Value Per Share(mrq)

0.93

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.53

Free Cash Flow(ytd)

-7.38M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

MRKR

Marker Therapeutics, Inc. Common Stock